Renaissance Technologies
CAPR icon

Renaissance Technologies’s Capricor Therapeutics CAPR Stock Holding History

Renaissance Technologies’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-137,500
Closed -$656K – 3550
2024
Q2 		$656K Buy
137,500
+84,350
+159% +$470K ﹤0.01% 2556
2024
Q1 		$361K Sell
53,150
-93,171
-64% -$451K ﹤0.01% 3004
2023
Q4 		$716K Buy
146,321
+103,700
+243% +$338K ﹤0.01% 2589
2023
Q3 		$146K Sell
42,621
-3,800
-8% -$21.4K ﹤0.01% 3163
2023
Q2 		$222K Buy
46,421
+15,900
+52% +$69.9K ﹤0.01% 3260
2023
Q1 		$129K Buy
30,521
+7,500
+33% +$32.3K ﹤0.01% 3410
2022
Q4 		$89K Buy
23,021
+12,821
+126% +$61.2K ﹤0.01% 3654
2022
Q3 		$61K Buy
+10,200
New +$52.2K ﹤0.01% 3705
2020
Q3 		– Sell
-198,800
Closed -$914K – 3395
2020
Q2 		$914K Buy
198,800
+95,185
+92% +$415K ﹤0.01% 2580
2020
Q1 		$124K Buy
103,615
+19,830
+24% +$27.7K ﹤0.01% 3186
2019
Q4 		$107K Buy
83,785
+43,272
+107% +$89.2K ﹤0.01% 3307
2019
Q3 		$150K Buy
+40,513
New +$140K ﹤0.01% 3208

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Renaissance Technologies's CAPR Position: Q3 2024 in Review

Renaissance Technologies sold out of Capricor Therapeutics (CAPR) in Q3 2024, closing a stake of 137,500 shares — an estimated $656K sold.

Renaissance Technologies first reported a position in CAPR in Q3 2019 and held it in 12 quarters. The position peaked at $914K in Q2 2020. 75 funds tracked by Wall St. Rank hold CAPR as of Q3 2024.

  • Renaissance Technologies reported no remaining Capricor Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 137,500 Capricor Therapeutics shares in Q3 2024, an estimated $656K.
  • Renaissance Technologies first reported a position in Capricor Therapeutics in Q3 2019 and held it in 12 quarters.
  • Renaissance Technologies's Capricor Therapeutics position peaked at $914K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.